Evaluate the Safety and Efficacy of CAR-T in the Treatment of Pancreatic Cancer.
Clinical trial NCT03267173 · UNKNOWN
Trial details
- NCT number
- NCT03267173
- Sponsor
- First Affiliated Hospital of Harbin Medical University
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-15
- Primary completion
- 2019-06-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.